ADMA Biologics (ADMA) Earnings Date, Estimates & Call Transcripts → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free ADMA Stock Alerts $6.91 +0.10 (+1.47%) (As of 05:38 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 9After Market ClosesConfirmedActual EPS (Feb. 28) $0.04 Beat By $0.02 Consensus EPS (Feb. 28) $0.02 Get ADMA Biologics Earnings AlertsEnter your email address below to receive the latest news and earnings results for ADMA and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueADMA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ADMA Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. ADMA Biologics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$0.05$0.05$0.05 Q2 20241$0.07$0.07$0.07 Q3 20241$0.08$0.08$0.08 Q4 20241$0.10$0.10$0.10 FY 20244$0.30$0.30 $0.30ADMA Earnings Date and InformationADMA Biologics last posted its quarterly earnings results on February 28th, 2024. The biotechnology company reported $0.04 earnings per share for the quarter, topping the consensus estimate of $0.02 by $0.02. The firm earned $73.90 million during the quarter, compared to analyst estimates of $73.50 million. ADMA Biologics has generated ($0.13) earnings per share over the last year (($0.13) diluted earnings per share). Earnings for ADMA Biologics are expected to grow by 66.67% in the coming year, from $0.30 to $0.50 per share. ADMA Biologics has confirmed that its next quarterly earnings report will be published on Thursday, May 9th, 2024. ADMA Biologics will be holding an earnings conference call on Thursday, May 9th at 4:30 PM Eastern. Interested parties can register for or listen to the call.. Read More ADMA Biologics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/9/2024Confirmed)------- 2/28/2024Q4 2023$0.02$0.04+$0.02$0.16$73.50 million$73.90 million11/8/2023Q3 2023($0.01)($0.01)-$0.01$62.13 million$67.30 million 8/9/2023Q2 2023($0.02)($0.02)-($0.01)$55.45 million$60.12 million 5/10/2023Q1 2023($0.05)($0.03)+$0.02($0.03)$51.35 million$56.91 million3/23/2023Q4 2022($0.06)($0.06)-($0.06)$49.02 million$49.98 million 11/9/2022Q3 2022($0.08)($0.08)-($0.08)$34.57 million$41.09 million Get the Latest News and Ratings for ADMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ADMA Biologics and its competitors with MarketBeat's FREE daily newsletter. 8/10/2022Q2 2022($0.09)($0.07)+$0.02($0.07)$31.17 million$33.91 million 5/11/2022Q1 2022($0.08)($0.10)($0.02)($0.07)$26.50 million$29.10 million 3/24/2022Q4 2021($0.10)($0.09)+$0.01($0.09)$26.00 million$26.38 million 11/10/2021Q3 2021($0.14)($0.13)+$0.01($0.13)$18.58 million$20.68 million 8/10/2021Q2 2021($0.15)($0.14)+$0.01($0.15)$16.55 million$17.83 million 5/11/2021Q1 2021($0.17)($0.16)+$0.01($0.16)$15.63 million$16.05 million ADMA Biologics Earnings - Frequently Asked Questions When is ADMA Biologics's earnings date? ADMA Biologics has confirmed that its next quarterly earnings data will be published on Thursday, May 9th, 2024. Learn more on ADMA's earnings history. Did ADMA Biologics beat their earnings estimates last quarter? In the previous quarter, ADMA Biologics (NASDAQ:ADMA) reported $0.04 earnings per share (EPS) to beat the analysts' consensus estimate of $0.02 by $0.02. Learn more on analysts' earnings estimate vs. ADMA's actual earnings. How much revenue does ADMA Biologics generate each year? ADMA Biologics (NASDAQ:ADMA) has a recorded annual revenue of $258.21 million. How much profit does ADMA Biologics generate each year? ADMA Biologics (NASDAQ:ADMA) has a recorded net income of -$28.24 million. ADMA has generated -$0.13 earnings per share over the last four quarters. What is ADMA Biologics's EPS forecast for next year? ADMA Biologics's earnings are expected to grow from $0.30 per share to $0.50 per share in the next year, which is a 66.67% increase. More Earnings Resources from MarketBeat Related Companies: NMRA Earnings Results INBX Earnings Results BEAM Earnings Results FDMT Earnings Results TWST Earnings Results CGEM Earnings Results FUSN Earnings Results SRRK Earnings Results RXRX Earnings Results TARS Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings? This page (NASDAQ:ADMA) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsAI “wealth window” is closing June 25thParadigm PressElon to Transform U.S. Economy? Porter & CompanyGold Set to EXPLODE!Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ADMA Biologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
